Chemo Switch May Benefit PDAC: Clin Onc News Report

FG_AUTHORS: MedPage Today

Patients with advanced pancreatic ductal adenocarcinoma (PDAC) who switched chemotherapy showed better outcomes, a study found.

Many U.S. surgeons are interested in oncoplastic surgery for breast cancer, though few use the technique.

Receiving chemotherapy before surgery improves survival in patients with gastric cancer, according to a recent study.

A new device could allow patients to assess their white blood cell levels from home, a new analysis found.

The FDA recently approved tisagenlecleucel (Kymriah) to treat adults with relapsed or refractory large B-cell lymphoma.

Clin Onc News Report is brought to MedPage Today readers by our friends at Clinical Oncology News, a McMahon Group title. Registration (free) may be required for some content.

2018-05-23T18:00:00-0400

Read more http://www.medpagetoday.com/hematologyoncology/prostatecancer/73072